Physician profile
Javier Amadeo
NPI 1396784690
$1,095.78
in general payments reported to CMS, 2019-2025
11 companies · $34.17 in 2025
The $34.17 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $56.30 · 2021: $71.06 · 2022: $319 · 2023: $43.05 · 2024: $215 · 2025: $34.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $292.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $463.39 | 2021-2024 | Intellis Adaptivestim, Catalyft Pl Expandable Interbody System, Unid_pass |
| Medtronic USA, INC. | $246.21 | 2019-2020 | |
| Carl Zeiss Meditec USA, INC. | $103.85 | 2022 | |
| Boston Scientific Corporation | $81.33 | 2019 | |
| Si-Bone, INC. | $60.06 | 2019 | |
| Globus Medical, INC. | $41.10 | 2024-2025 | Xlif, Modulus |
| Biodelivery Sciences International, INC. | $26.09 | 2019-2020 | |
| Nuvasive, INC. | $23.02 | 2023 | Xlif |
| Cook Medical LLC | $18.11 | 2025 | Cook |
| Abbott Laboratories | $17.84 | 2024 | Proclaim |
| Kci USA, INC. | $14.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javier Amadeo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.